• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Development of New MDR-Tuberculosis Drugs

Development of New MDR-Tuberculosis Drugs

9781616682330
258.24 zł
232.41 zł Save 25.83 zł Tax included
Lowest price within 30 days before promotion: 232.41 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
The emergence of resistance to anti-tuberculosis drugs, particularly of MDR-TB and newly XDR-TB, has become a major public health problem. The current treatment regiment has several disadvantages, i.e. long treatment period (DOTS takes minimum 6 months) during which tubercle bacilli mutant become resistant to one or more drugs; side effects of the used drugs; co-infection of HIV/AIDS. The emergence of MDR-TB has made many currently available anti-TB drugs ineffective. Sleeping latent forms of mutant bacilli resistant against common anti-TB drugs pose the risk of epidemic for the new generation. This book outlines the recent advances in the development of new multi-drug-resistant tuberculosis (MDR-TB) drugs.
Product Details
73408
9781616682330
9781616682330

Data sheet

Publication date
2010
Issue number
1
Cover
paperback
Dimensions (mm)
230.00 x 155.00
Weight (g)
186
  • Introduction; Resistance to Commonly Used Drugs, Mechanism of the Action; Research of Novel MDR Potential Drugs; Conclusion; Index.
Comments (0)